好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Remarkable Improvement of Initially Devastating Post-SARS-CoV-2 Myelitis After Administration of Steroids and Plasmapheresis
General Neurology
P6 - Poster Session 6 (8:00 AM-9:00 AM)
4-013

To increase awareness of myelitis as an unusual complication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.

SARS-CoV-2 infection is a relatively new medical entity. Myelitis is a challenging and uncommon complications of SARS-CoV-2 infection that does not have established evidence based treatment recommendations. 
Patient chart review 

We present a 60-year-old male with a past medical history of hypertension, anxiety, and recent SARS-CoV-2 infection who presented to our institution for evaluation of ascending numbness and gait instability. The initial neurological examination revealed decreased pinprick sensation up to the level of the nipples, absent vibration in toes, ankles, knees, and severe ataxia in bilateral lower extremities. The Romberg test was positive, and the patient had prominent gait instability. An MRI of the brain showed incidental finding of superior cerebellar vermis atrophy. An MRI of the spine showed numerous patchy non-enhancing T2 hyperintense lesions in the cervical and thoracic spine. A lumbar puncture was unremarkable. Autoimmune encephalopathy panel results from serum and CSF were negative. The infectious workup for syphilis, West Nile virus, Epstein-Barr virus, cytomegalovirus in serum and CSF was normal. Heavy metals, copper, zinc, and vitamin B6 were unremarkable. The patient was diagnosed with post-infectious myelitis in the setting of recent SARS-CoV-2 infection. He received 1g of IV methylprednisolone for 5 days. Due to improvement, he was discharged to a rehabilitation facility; however, the patient clinically deteriorated and was readmitted for severe bilateral lower extremity weakness. During the second hospitalization, he underwent 5 sessions of plasmapheresis and IV methylprednisolone. After prolonged rehabilitation and a slow steroid taper, the patient returned to his baseline without residual deficits.

Post-infectious myelitis can present as a rare complication of SARS-CoV-2. A combination of high-dose IV steroids, plasmapheresis, and intensive rehabilitation can be beneficial and result in significant recovery. 
Authors/Disclosures
Amra Sakusic, MD
PRESENTER
Dr. Sakusic has nothing to disclose.
Mohammed K. Badi, MD (Mayo Clinic Jacksonville) Dr. Badi has nothing to disclose.
Alejandro A. Rabinstein, MD, FAAN (Mayo Clinic) Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.